NASDAQ: SIONSionna Therapeutics Inc Stock Ownership - Who owns Sionna Therapeutics?
Insider buying vs selling
Have Sionna Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Atlas Venture Fund XI LP | 10% Owner | 2025-02-10 | 60,000 | $18.00 | $1.08MBuy |
| Bruce Booth | Director | 2025-02-10 | 60,000 | $18.00 | $1.08MBuy |
| Orbimed Advisors LLC | Director | 2025-02-10 | 550,000 | $18.00 | $9.90MBuy |
| Ra Capital Management LP | Director | 2025-02-10 | 1,022,586 | $18.00 | $18.41MBuy |
| Ra Capital Management LP | Director | 2025-02-10 | 102,414 | $18.00 | $1.84MBuy |
| Peter A. Thompson | Director | 2025-02-10 | 550,000 | $18.00 | $9.90MBuy |
| Tpg GP A LLC | 10% Owner | 2025-02-10 | 1,125,000 | $18.00 | $20.25MBuy |
SION insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when SION insiders and whales buy or sell their stock.
SION Shareholders
What type of owners hold Sionna Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Ra Capital Management LP | 23.67% | 10,445,322 | $177.47M | Institution |
| Tpg GP A LLC | 15.15% | 6,684,962 | $113.58M | Institution |
| Tpg GP A LLC | 15.15% | 6,684,962 | $113.58M | Insider |
| Peter A. Thompson | 8.40% | 3,704,959 | $62.95M | Insider |
| Orbimed Advisors LLC | 8.40% | 3,704,959 | $62.95M | Insider |
| Orbimed Advisors LLC | 8.40% | 3,704,959 | $62.95M | Institution |
| Atlas Venture Life Science Advisors LLC | 8.37% | 3,694,020 | $62.76M | Institution |
| Bruce Booth | 8.37% | 3,694,020 | $62.76M | Insider |
| Atlas Venture Fund XI LP | 8.37% | 3,694,020 | $62.76M | Insider |
| Viking Global Investors LP | 6.69% | 2,952,754 | $50.17M | Institution |
SION vs Biotech Stocks
Sionna Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.